Previous 10 |
IsoPlexis to Present Data at SITC 2021 Connecting Genetic Drivers to Functional Proteomics Company to introduce new immunology applications for Duomic®, a novel simultaneous single-cell transcriptomics and functional proteomics platform, and clinical single-cell proteomics ...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
IsoPlexis to Report Third Quarter Financial Results on November 10, 2021 PR Newswire BRANFORD, Conn. , Oct. 26, 2021 /PRNewswire/ -- IsoPlexis Corporation (Nasdaq: ISO), a leader in functional single-cell proteomics, today announced it will report financial ...
News, Short Squeeze, Breakout and More Instantly...
(NewsDirect) IsoEnergy Limited (TSX-V:ISO) president Tim Gabruch, delves into the strategic merger with Consolidated Uranium, marking a pivotal transformation into a global uranium industry contender. In an interview with Proactive's Angela Harmantas at PDAC 2024, Gabruch noted that t...
SASKATOON, Saskatchewan, Jan. 19, 2024 (GLOBE NEWSWIRE) -- IsoEnergy Ltd. (“IsoEnergy” or the “Company”) (TSXV: ISO; OTCQX: ISENF) is pleased to announce that it has entered into an amended agreement with Eight Capital, as co-lead underwriter and joint bookrunner o...
SASKATOON, Saskatchewan, Jan. 18, 2024 (GLOBE NEWSWIRE) -- IsoEnergy Ltd. (“IsoEnergy” or the “Company”) (TSXV: ISO; OTCQX: ISENF) is pleased to announce that it has entered into an agreement with Eight Capital to act as co-lead underwriter and joint bookrunner on ...